A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia

A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Outpatients With Schizophrenia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01212575

Enrollment

186

Registered

2010-09-30

Start date

2010-10-31

Completion date

2011-02-28

Last updated

2011-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

Mental disorder, Antipsychotic treatment

Brief summary

The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Adults with a diagnosis of schizophrenia from a district psychiatric clinic in Denmark * Patients who have received at least one dose of Seroquel XR or Seroquel IR during January - March 2010

Exclusion criteria

* Patients already participating in a clinical study during the study-period.

Design outcomes

Primary

Measure	Time frame
How Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia	Month 1

Secondary

Measure	Time frame
Co-morbidities of patients with schizophrenia receiving Seroquel XR and IR	Month 1
Whether Seroquel XR and Seroquel IR are used to treat different types of outpatients with schizophrenia by evaluation of patient characteristics	Month 1
The treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR	Month 1

Countries

Denmark

Outcome results